Loading clinical trials...
Loading clinical trials...
Combination of involved field radiotherapy for the control of macroscopic disease and CD20 antibody Rituximab for the control of microscopic remainders in other regions in patients with early stage no...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Klaus Herfarth, MD
Collaborators
NCT02732275 · Lymphoma, Malignant, Non-hodgkin Lymphoma
NCT02916979 · Leukemia, Lymphoid, Leukemia, Myeloid, and more
NCT01432951 · Solid Tumor, Lymphoma, Malignant
NCT00741871 · Lymphoma, Malignant, Hodgkin's Lymphoma, and more
Charité Campus Mitte
Berlin
Charité Campus Benjamin-Franklin
Berlin
Charité Campus Buch
Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions